TriSalus Life Sciences, Inc. Logo

TriSalus Life Sciences, Inc.

Oncology company integrating drug delivery with immunotherapy to treat solid tumors.

TLSI | US

Overview

Corporate Details

ISIN(s):
US58507N2045 (+2 more)
LEI:
Country:
United States of America
Address:
6272 WEST 91ST AVENUE, 80031 WESTMINSTER

Description

TriSalus Life Sciences is an oncology company focused on developing treatments for solid tumors, particularly in the liver and pancreas. The company's therapeutic platform integrates its proprietary Pressure-Enabled Drug Delivery™ (PEDD™) technology with investigational immunotherapies. This integrated approach is designed to overcome critical barriers to treatment, such as high intratumoral pressure and the immunosuppressive tumor microenvironment, which can limit the efficacy of cancer therapies. Key components of its platform include the TriNav® Infusion System for targeted drug delivery and the investigational immunotherapy candidate, nelitolimod. The company aims to improve patient outcomes by enhancing the delivery and effectiveness of treatments, often in combination with systemic immunotherapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all TriSalus Life Sciences, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TriSalus Life Sciences, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TriSalus Life Sciences, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Avalo Therapeutics, Inc. Logo
Clinical-stage biotech developing treatments for immune-mediated inflammatory diseases.
United States of America
AVTX
Azenta, Inc. Logo
Offers sample management, storage, and multiomics solutions for life sciences.
United States of America
AZTA
BenevolentAI Logo
Applies artificial intelligence to accelerate drug discovery and development.
United Kingdom
BAI
bioAffinity Technologies, Inc. Logo
Develops noninvasive diagnostics and targeted therapeutics for cancer.
United States of America
BIAF
BioArctic Logo
Biopharmaceutical firm developing antibody therapies for neurodegenerative diseases.
Sweden
BIOA
BioInfra Co.,Ltd. Logo
Develops multi-biomarker blood tests for early cancer screening and gene treatments.
South Korea
199730
BioInfra Life Science Inc. Logo
Develops multi-biomarker blood tests for early cancer screening and gene treatments.
South Korea
266470
BioNexus Gene Lab Corp Logo
Develops gene-based diagnostics for early detection of disease susceptibility.
United States of America
BGLC
Biophytis S.A. Logo
Clinical-stage biotech developing therapeutics for age-related degenerative diseases.
France
ALBPS
BioRestorative Therapies, Inc. Logo
Develops adult stem cell therapies for degenerative disc and metabolic disorders.
United States of America
BRTX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.